
Magnera (NYSE:MAGN) expects comparable EBITDA to grow about 6% in fiscal 2027 at the midpoint of its guidance, as merger synergies and cost-saving initiatives help offset inflation and uneven demand across its markets.
The company forecast comparable EBITDA of $400 million at the midpoint on a constant-currency basis and free cash flow of $110 million to $130 million. Management said it expects cash generation to be weighted toward the second half of the fiscal year, as it was in 2026.
Cash flow and debt reduction
Magnera generated $115 million in free cash flow during fiscal 2026 and reduced debt by $122 million, including $57 million in the fourth quarter, Begle said. Chief Financial Officer Jim Till said the fourth-quarter repayment included both bonds and term loans, with the larger portion going toward the term loan.
Till said the company ended the year with approximately $600 million in available liquidity and remains focused on reducing leverage to its target of 3 times. At the midpoint of its 2027 free cash flow guidance, Magnera intends to use approximately $120 million for debt reduction, which Till said would bring leverage to roughly 3.6 times.
The fiscal 2027 cash flow forecast includes approximately $85 million in capital spending. Begle said the increase from fiscal 2026 is primarily tied to innovation projects and opportunities in markets where Magnera sees differentiated products and room for growth.
Volume softness offsets pricing gains
Fourth-quarter revenue rose 2% in the Americas, supported by pricing actions and demand in infrastructure-related construction markets. Softer healthcare demand contributed to a 2% net organic decline, while adjusted EBITDA rose 7% to $65 million, Till said.
In the rest-of-world segment, revenue increased 1% as pricing and strength in wipes helped offset weaker demand in parts of Europe. Organic volume fell 6%, but adjusted EBITDA increased 10% to $33 million, aided by cost management and operational improvements.
Till said companywide earnings were consistent with the expectations outlined on the prior quarter’s call, despite softer-than-anticipated volume in the latter half of the fourth quarter. Begle said fourth-quarter earnings improved 8% from a year earlier, while full-year earnings rose nearly 4%.
Begle attributed some of the fourth-quarter weakness to delayed orders and softness in certain European categories. He said demand in Europe had shown signs of recovery early in the new fiscal year, although customer inventory rebalancing and changing order patterns continue to affect volumes.
Inflation and productivity shape outlook
For fiscal 2027, Begle described the outlook as cautiously optimistic in the Americas, where he expects low-single-digit growth, and roughly flat to slightly negative in Europe. Management’s guidance assumes approximately flat global volume at the midpoint, with the upper and lower ends of the range largely driven by volume differences.
Magnera is working to offset inflation through productivity and, where appropriate, price increases, Begle said. The company was roughly 70% hedged for European energy needs in fiscal 2027. Till said the forecast includes approximately $10 million in European energy inflation, alongside other inflationary pressures.
Till said rollover benefits from fiscal 2026 actions are expected to total roughly $20 million in fiscal 2027, weighted toward the first half. Those compare with approximately $45 million in benefits realized during fiscal 2026. Further actions under Project CORE are included in the $400 million EBITDA midpoint, he said.
Magnera also expects continued demand strength in wipes and infrastructure. A new high-performance blown film line in Dombühl, Germany, is expected to produce and ship commercial orders in the first calendar quarter of 2027, Begle said.
Impairment and longer-term priorities
Asked about a $106 million fourth-quarter impairment charge, Till said the primary factor was pressure on the company’s internal carrying value relative to fair value, given the difference between its trading multiple and the multiple at the inception of the transaction that formed Magnera.
Begle said the company continues to evaluate potential inorganic opportunities but remains committed to its leverage target. He added that he was not aware of an available transaction that made sense for Magnera at present.
About Magnera (NYSE:MAGN)
Magnera Corporation is a global manufacturer of specialty materials, including nonwoven fabrics, films and related products. Its materials are used in personal care and hygiene products, healthcare, wipes, filtration, building and construction, and food packaging. The company was formed in 2024 through the combination of Glatfelter and Berry Global’s Health, Hygiene and Specialties business. Magnera serves customers in markets around the world.
